世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037837

非アルコール性脂肪性肝炎(NASH)の世界市場レポート(2024年)

The Business Research Company

Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024

発刊日 2024/02/23

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000037837

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、非アルコール性脂肪性肝炎(NASH)の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている非アルコール性脂肪性肝炎(NASH)市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ タイプ別
      ◇ 固体
      ◇ 液体
    ➣ 製品別
      ◇ ビタミンEとピオグリタゾン
      ◇ オカリバ
      ◇ エラフィブラノール
      ◇ セロンセルチブとセニクリビロック
      ◇ その他の製品
    ➣ 疾病原因別
      ◇ 高血圧
      ◇ 心臓病
      ◇ 高脂血症
      ◇ 2型糖尿病
      ◇ 肥満
    ➣ 販売チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンラインプロバイダー
    ➣ 用途別
      ◇ 経口
      ◇ 非経口
  • 調査企業
    ➣ NGM Biopharmaceuticals Inc.
    ➣ Novartis AG
    ➣ AstraZeneca plc.
    ➣ GlaxoSmithKline plc.
    ➣ F. Hoffmann-La Roche AG
  • 調査国
    オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Non-Alcoholic Steatohepatitis (NASH) Market Characteristics

3. Non-Alcoholic Steatohepatitis (NASH) Market Trends And Strategies

4. Non-Alcoholic Steatohepatitis (NASH) Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Non-Alcoholic Steatohepatitis (NASH) Market Size and Growth
5.1. Global Non-Alcoholic Steatohepatitis (NASH) Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Non-Alcoholic Steatohepatitis (NASH) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Non-Alcoholic Steatohepatitis (NASH) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Non-Alcoholic Steatohepatitis (NASH) Market Segmentation
6.1. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Solid
Liquid
6.2. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Vitamin E and Pioglitazone
Ocaliva
Elafibranor
Selonsertib and Cenicriviroc
Other Products
6.3. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Disease Cause, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hypertension
Heart Disease
High Blood Lipid
Type 2 Diabetes
Obesity
6.4. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Provider
6.5. Global Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral

7. Non-Alcoholic Steatohepatitis (NASH) Market Regional And Country Analysis
7.1. Global Non-Alcoholic Steatohepatitis (NASH) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Non-Alcoholic Steatohepatitis (NASH) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market
8.1. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Non-Alcoholic Steatohepatitis (NASH) Market
9.1. China Non-Alcoholic Steatohepatitis (NASH) Market Overview
9.2. China Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Non-Alcoholic Steatohepatitis (NASH) Market
10.1. India Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Non-Alcoholic Steatohepatitis (NASH) Market
11.1. Japan Non-Alcoholic Steatohepatitis (NASH) Market Overview
11.2. Japan Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Non-Alcoholic Steatohepatitis (NASH) Market
12.1. Australia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market
13.1. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Non-Alcoholic Steatohepatitis (NASH) Market
14.1. South Korea Non-Alcoholic Steatohepatitis (NASH) Market Overview
14.2. South Korea Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market
15.1. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market Overview
15.2. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Non-Alcoholic Steatohepatitis (NASH) Market
16.1. UK Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Non-Alcoholic Steatohepatitis (NASH) Market
17.1. Germany Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Non-Alcoholic Steatohepatitis (NASH) Market
18.1. France Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Non-Alcoholic Steatohepatitis (NASH) Market
19.1. Italy Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Non-Alcoholic Steatohepatitis (NASH) Market
20.1. Spain Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market
21.1. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market Overview
21.2. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Non-Alcoholic Steatohepatitis (NASH) Market
22.1. Russia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Non-Alcoholic Steatohepatitis (NASH) Market
23.1. North America Non-Alcoholic Steatohepatitis (NASH) Market Overview
23.2. North America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Non-Alcoholic Steatohepatitis (NASH) Market
24.1. USA Non-Alcoholic Steatohepatitis (NASH) Market Overview
24.2. USA Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Non-Alcoholic Steatohepatitis (NASH) Market
25.1. Canada Non-Alcoholic Steatohepatitis (NASH) Market Overview
25.2. Canada Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Non-Alcoholic Steatohepatitis (NASH) Market
26.1. South America Non-Alcoholic Steatohepatitis (NASH) Market Overview
26.2. South America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Non-Alcoholic Steatohepatitis (NASH) Market
27.1. Brazil Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Non-Alcoholic Steatohepatitis (NASH) Market
28.1. Middle East Non-Alcoholic Steatohepatitis (NASH) Market Overview
28.2. Middle East Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Non-Alcoholic Steatohepatitis (NASH) Market
29.1. Africa Non-Alcoholic Steatohepatitis (NASH) Market Overview
29.2. Africa Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Non-Alcoholic Steatohepatitis (NASH) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Non-Alcoholic Steatohepatitis (NASH) Market Competitive Landscape And Company Profiles
30.1. Non-Alcoholic Steatohepatitis (NASH) Market Competitive Landscape
30.2. Non-Alcoholic Steatohepatitis (NASH) Market Company Profiles
30.2.1. NGM Biopharmaceuticals Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Novartis AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. AstraZeneca plc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. GlaxoSmithKline plc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. F. Hoffmann-La Roche AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Non-Alcoholic Steatohepatitis (NASH) Market Other Major And Innovative Companies
31.1. The Takeda Pharmaceutical Company Limited
31.2. Gilead Sciences Inc.
31.3. Novo Nordisk A/S
31.4. Genfit SA
31.5. Cadila Pharmaceuticals Ltd.
31.6. Intercept Pharmaceuticals Inc.
31.7. Enanta Pharmaceuticals Inc.
31.8. Blade Therapeutics Inc.
31.9. Cempra Pharmaceuticals Inc.
31.10. Galmed Pharmaceuticals Inc.
31.11. Immuron Limited
31.12. Terns Pharmaceuticals Inc.
31.13. Tobira Therapeutics Inc.
31.14. Arena Pharmaceuticals Inc.
31.15. Vivus LLC

32. Global Non-Alcoholic Steatohepatitis (NASH) Market Competitive Benchmarking

33. Global Non-Alcoholic Steatohepatitis (NASH) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis (NASH) Market

35. Non-Alcoholic Steatohepatitis (NASH) Market Future Outlook and Potential Analysis
35.1 Non-Alcoholic Steatohepatitis (NASH) Market In 2028 - Countries Offering Most New Opportunities
35.2 Non-Alcoholic Steatohepatitis (NASH) Market In 2028 - Segments Offering Most New Opportunities
35.3 Non-Alcoholic Steatohepatitis (NASH) Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

この商品のレポートナンバー

0000037837

TOP